Tag: pharmaceuticals

  • Advaxis, Karolinska Institutet to Collaborate on Allergies

    Advaxis Inc., a biotechnology company in Princeton, New Jersey says it will partner with a lab at Stockholm’s Karolinska Institutet on research leading to preventions or treatments for cat allergies. Financial terms of the collaboration were not revealed. The company plans to work with the lab headed by Marianne van Hage, a professor of immunology…

  • Programmed Nanoparticles Tested as Cancer Treatments

    Researchers from four universities, three hospitals, and the biopharmaceutical company BIND Biosciences are testing a new form of cancer therapy using nanoscale particles designed to deliver a dose of targeted medicine to solid tumors. The findings, including results of early clinical trials, are published in this week’s issue of the journal Science Translational Medicine (paid…

  • Patent Issued for Technology to Suppress Stem Cell Rejection

    Athersys Inc., a biotechnology company in Cleveland, Ohio, has received a patent for its process to reduce or suppress graft-versus-host disease associated with bone-marrow stem cell transplants used to treat leukemia and related disorders. Patent 8,147,824 was issued yesterday by the U.S. Patent and Trademark Office and assigned to Athersys, as well as the Oregon…

  • DNA Sequencing Extended to Cancer Treatment Decisions

    Medical researchers at Washington University in St. Louis have adapted DNA sequencing technology to map the genetic evolution of disease and monitor response to treatment. Up to now, researchers have used genomic sequencing to identify mutations at the root of a patient’s tumor, but that technology can also help guide treatment decisions, according to Elaine…

  • Biotech Secures $25 Million in Series B Financing

    AlloCure Inc., a privately-held biotechnology company in Burlington, Massachusetts, says it has closed a $25 million deal for series B venture financing. The series B round — the second financing installment after initial start-up — includes new syndicate member Lundbeckfond Ventures, as well as previous investors SV Life Sciences and Novo A/S. The company is…

  • Trial Highlights Metastatic Breast Cancer Drug Effectiveness

    First results from a clinical trial of the drug trastuzumab emtansine (T-DM1) made by Genentech, a division of the global pharmaceutical company Roche, show the drug extended the lives of metastatic breast cancer patients without the disease getting worse. The study enrolled people with HER2-positive metastatic breast cancer who had previously received treatment with the…

  • BASF to Boost R&D Spending, Staffing

    The global chemical company BASF in Ludwigshafen, Germany says it plans to increase its research and development spending to €1.7 billion ($2.3 billion) in 2012, and align its R&D programs more closely with high-growth business fields. The company also announced plans to increase its research staff, particularly in Asia and the Americas. The €1.7 billion…

  • European Patent Office Filings, Awards Gain in 2011

    The European Patent Office, based in Munich, says the number of patent applications and awards increased in 2011, with applications from Asia now making up about a third of the total. The largest single technical field among applications was medical technology, which had almost as many filings in 2011 as pharmaceuticals and biotechnology combined. EPO…

  • Trial to Test Bacteria Elimination on Aspirin Tolerance

    A clinical trial led by University of Nottingham in the U.K. will test the effect of removing a common stomach bacteria on making aspirin safer for some patients. The Helicobacter Eradication Aspirin Trial (HEAT) will also involve academics from Durham, Southampton, Oxford, and Birmingham universities. The trial will investigate if removing the bacterium Helicobacter pylori…

  • Process Developed for More Nutritional Supplement Stability

    A Purdue University food scientist in West Lafayette, Indiana has develop a method for enveloping nutritional supplements to protect them from degradation. The process devised by Purdue professor Srinivas Janaswamy and former student Susanne Youngren, now at University of Hawaii in Hilo, appeared online earlier this month in the journal Food & Function (paid subscription…